Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Founded in 2016, Infervision stands at the forefront of AI-driven medical technology, dedicated to enhancing multidisciplinary healthcare services and operations through innovative artificial intelligence solutions. Their advanced AI offerings are designed to assist healthcare professionals across a spectrum of tasks, including disease screening, diagnosis, intervention, treatment, patient management, and medical research. Among their array of solutions, InferRead CT Lung specializes in detecting lung nodules from chest CT scans, while InferRead DR Chest focuses on identifying chest abnormalities via X-ray imaging. Moreover, InferRead CT Coronary is tailored for recognizing coronary artery stenosis during coronary CT angiography, and InferRead CT Stroke is adept at triaging hemorrhages from brain CT scans. The company also provides InferRead CT Bone for spotting chest fractures in CT images and InferRead CT Pneumonia for diagnosing and managing pneumonia cases. Beyond these, their offerings extend to InferOperate, which facilitates 3D reconstruction for thoracic, liver, and urological surgical procedures, and InferCare, a tool designed for effective patient management and image follow-up. Additionally, InferScholar acts as an AI-enhanced resource for medical research, further solidifying Infervision's commitment to transforming healthcare through AI technology. This comprehensive suite of solutions positions Infervision as a pivotal player in the evolution of medical practices.
Description
Healthcare providers and pharmaceutical firms leverage RetinAI's software platform to effectively manage their data while benefiting from enhanced insights through automated AI analysis, thereby optimizing both clinical and research workflows. This unified data platform allows users to access and manage their information from any location at any time. It supports a variety of formats, including DICOM-compliant and proprietary types. By utilizing AI, data is harmonized, organized, aggregated, and analyzed on a large scale to uncover insights related to disease progression, treatment outcomes, and predictions of disease advancement. Additionally, the platform facilitates collaborative research within organizations by providing secure cloud-based access to data. It serves as a central hub for data, medical, and digital teams. Users can conduct AI-driven analysis on their OCT volumes, focusing on layer and fluid segmentation. Immediate evaluations can be performed to consolidate insights into a single platform. Collaborators can be swiftly invited to access and interact with datasets according to specified permission levels, fostering a more integrated research environment. This comprehensive approach not only streamlines data management but also enhances collaborative efforts across different teams and disciplines.
API Access
Has API
No
API Access
Has API
No
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Customer Support
Business Hours
No
Live Rep (24/7)
Yes
Online Support
Yes
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
Yes
In Person
Yes
Types of Training
Training Docs
Yes
Webinars
Yes
Live Training (Online)
Yes
In Person
Yes
Vendor Details
Company Name
Infervision
Founded
2016
Country
United States
Website
global.infervision.com
Vendor Details
Company Name
RetinAI
Country
Switzerland
Website
www.retinai.com